Nifedipine for Acute Tocolysis of Preterm Labor
Status: | Completed |
---|---|
Conditions: | Women's Studies |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | 16 - 44 |
Updated: | 2/13/2019 |
Start Date: | May 5, 2014 |
End Date: | October 29, 2018 |
The purpose of this study is to determine if nifedipine treatment of women in preterm labor
receiving corticosteroids results in postponement of delivery when compared to placebo.
receiving corticosteroids results in postponement of delivery when compared to placebo.
Inclusion Criteria:
- Between 16 and 44 years of age inclusive
- Singleton pregnancy
- Intact membranes
- Between 28-0/7 weeks and 33-6/7 weeks' gestation inclusive
- Reported or documented uterine activity
- Cervical dilation between 2 cm and 4 cm inclusive
Exclusion Criteria:
- Multifetal gestation
- Less than 28 weeks' gestation
- 34 or more weeks' gestation
- Ruptured membranes
- More than 4 cm dilated
- Previously received a course of corticosteroids for fetal lung maturation
- Oligohydramnios
- Fetal growth restriction
- Chorioamnionitis or temperature of at least 38.0 degrees Celsius
- Fetal death
- Preeclampsia
- Suspected placental abruption or placenta previa
- Lethal fetal malformation or amniotic fluid index at least 35
- Systolic BP < 90 mmHg or diastolic BP < 50 mmHg
- Baseline tachycardia (pulse >120 after 2 consecutive measurements 30 minutes apart)
- Chronic hypertension treated with antihypertensives in pregnancy
- Seizure disorder or HIV
- Maternal allergy to nifedipine
- Known maternal cardiac disease
- Women who have received progesterone therapy in the second or third trimester for
prevention of preterm birth
We found this trial at
1
site
5201 Harry Hines Blvd
Dallas, Texas 75235
Dallas, Texas 75235
(214) 590-8000
Principal Investigator: Josiah S Hawkins, MD
Parkland Memorial Hospital As our community's public health system, Parkland is the foundation for a...
Click here to add this to my saved trials